|
VanEck ChiNext ETF
|
||||||||||||||||||
- Description
- Performance
- Comps
Fundamentals
Valuation
Rating
| CNXT tracks the ChiNext Index, which includes the 100 largest and most liquid stocks listed and trading on the ChiNext Market of the Shenzhen Stock Exchange. The ChiNext Index is comprised of China A-shares. |
| Category | Emerging Market Equities |
| Fund Sponsor | Van Eck Associates |
| Website | www.vaneck.com |
| Inception date | Jul 23, 2014 |
| Assets (mns) | $62 |
| Currency | USD |
| Expense ratio | 65 bp |
| Distributions | Annually |
| Regulation | Open-End Investment Company |
| Custodian | Bank of New York Mellon |
| Weighting | Market Cap |
| Index replication | Full |
| Uses derivatives | No |
| Options available | Yes |
| No. of constituents | 101 |
| Wgt avg mkt cap (mns) | $3,364 |
| Large cap (>$10bn) | 25.2% |
| Mid cap ($2-10bn) | 68.9% |
| Small cap (<$2bn) | 5.9% |
| Developed mkts | 0.0% |
| Emerging mkts | 100.0% |
| CONTEMPORARY AMPEREX TECHN-A | 18.8 % |
| ZHONGJI INNOLIGHT CO LTD-A | 8.4 % |
| EOPTOLINK TECHNOLOGY INC., LTD. CL | 6.5 % |
| EAST MONEY INFORMATION CO-A | 5.1 % |
| SUNGROW POWER SUPPLY CO LT-A | 4.8 % |
| VICTORY GIANT TECHNOLOGY -A | 3.2 % |
| SUZHOU TFC OPTICAL COMMUNI-A | 2.7 % |
| SHENZHEN INOVANCE TECHNOLO-A | 2.6 % |
| SHENZHEN MINDRAY BIO-MEDIC-A | 2.0 % |
| WENS FOODSTUFF GROUP CO L-A | 1.8 % | Total | 55.9 % |
|---|
| CHINA | 93.2 % |
HISTORICAL PERFORMANCE 

| Custom date range | Compare to | ||
| thru |
| Year-to-date | 1 year | 5 years | 10 years | Since Incep. |
| 5.8% | 64.1% | 0.6% | 5.9% | 6.4% |
| versus... | Beta | R-squared |
| S&P500 | 0.60 | 14% |
| MSCI EAFE | 0.83 | 19% |
| MSCI Emg. Mkts. | 1.09 | 39% |
| Recent close | $44.25 |
| 30d moving avg. | $45.62 |
| Annualized volatility | 37.7% |
| Short interest (ETF) | 5.0% |
| Relative strength (RSI) | 48 |
| Avg. volume (thou.) | 32 |
| Turnover | 2.3% |
| Bid/Ask (% of price) | 0.39% |
| ADV underlying (mns) | $2,182 |
FINDING ALTERNATIVE FUNDS
Below is a list of 51 potential alternatives to the VanEck ChiNext ETF ETF based on the alternatives' overlap in portfolio holdings with CNXT. Consider funds with lower expense ratios and/or higher ALTAR Score™ ratings as possible alternatives.
| Benchmark ticker: | CNXT | Expense: | 65 bp | ALTAR Score™: | 3.2% |
| Ticker | Fund Name |
Overlap1 vs CNXT (%) |
Expense ratio (bp) |
Savings vs CNXT (bp) |
ALTAR Score™ (%) |
ALTAR vs CNXT (%) |
| TCHI | iShares MSCI China Multisector Tech ETF | 1.0 | 59 | 6 | 15.3 | +12.1 |
| ASHR | Xtrackers Harvest CSI 300 China A-Shares ETF | 0.7 | 65 | 0 | 6.6 | +3.3 |
| KARS | KraneShares Electric Vehicles & Future Mobility Index ETF | 0.5 | 72 | -7 | 2.2 | -1.0 |
| CQQQ | Invesco China Technology ETF | 0.5 | 70 | -5 | 16.8 | +13.6 |
| POW | VistaShares Electrification Supercycle ETF | 0.4 | 75 | -10 | 2.5 | -0.8 |
| CXSE | WisdomTree China ex-State-Owned Enterprises Fund | 0.3 | 32 | 33 | 13.8 | +10.6 |
| CNYA | iShares MSCI China A ETF | 0.3 | 60 | 5 | 6.8 | +3.5 |
| ICLN | iShares Global Clean Energy ETF | 0.3 | 41 | 24 | 2.0 | -1.2 |
| GMET | VanEck Green Metals ETF | 0.3 | 63 | 2 | 5.7 | +2.5 |
| FLCH | Franklin FTSE China ETF | 0.2 | 19 | 46 | 17.2 | +13.9 |
| KURE | KraneShares MSCI All China Health Care Index ETF | 0.2 | 65 | 0 | 2.5 | -0.8 |
| EMCR | Xtrackers Emerging Markets Carbon Reduction and Climate Impr | 0.2 | 15 | 50 | 9.8 | +6.6 |
| SCHE | Schwab Emerging Markets Equity ETF | 0.1 | 11 | 54 | 10.0 | +6.8 |
| GXC | SPDR S & P China ETF | 0.1 | 59 | 6 | 18.1 | +14.8 |
| XSOE | WisdomTree Emerging Markets ex-State-Owned Enterprises Fund | 0.1 | 32 | 33 | 8.3 | +5.1 |
| GEM | Goldman Sachs ActiveBeta Emerging Markets Equity ETF | 0.1 | 45 | 20 | 9.0 | +5.8 |
| DGS | WisdomTree Emerging Markets SmallCap Dividend Fund | 0.1 | 58 | 7 | 8.8 | +5.5 |
| FLAX | Franklin FTSE Asia Ex Japan ETF | 0.1 | 19 | 46 | 8.1 | +4.8 |
| MCHI | iShares MSCI China ETF | 0.1 | 59 | 6 | 19.4 | +16.1 |
| BKEM | BNY Mellon Emerging Markets Equity ETF | 0.1 | 11 | 54 | 8.8 | +5.5 |
| DBEM | Xtrackers MSCI Emerging Markets Hedged Equity ETF | 0.1 | 66 | -1 | 8.0 | +4.8 |
| DFAE | Dimensional Emerging Core Equity Market ETF | 0.0 | 35 | 30 | 7.7 | +4.5 |
| JEMA | JPMorgan ActiveBuilders Emerging Markets Equity ETF | 0.0 | 33 | 32 | 7.5 | +4.3 |
| DFSE | Dimensional Emerging Markets Sustainability Core 1 ETF | 0.0 | 41 | 24 | 7.5 | +4.3 |
| DFEM | Dimensional Emerging Markets Core Equity 2 ETF | 0.0 | 38 | 27 | 7.7 | +4.5 |
| GMF | SPDR S&P Emerging Asia Pacific ETF | 0.0 | 49 | 16 | 9.5 | +6.2 |
| DEHP | Dimensional Emerging Markets High Profitability ETF | 0.0 | 41 | 24 | 5.5 | +2.3 |
| SPEM | SPDR Portfolio Emerging Markets ETF | 0.0 | 7 | 58 | 10.0 | +6.8 |
| GSEE | Goldman Sachs MarketBeta Emerging Markets Equity ETF | 0.0 | 36 | 29 | 8.5 | +5.2 |
| VWO | Vanguard FTSE Emerging Markets ETF | 0.0 | 7 | 58 | 9.7 | +6.5 |
| EMXF | iShares ESG Advanced MSCI EM ETF | 0.0 | 16 | 49 | 7.6 | +4.4 |
| EEM | iShares MSCI Emerging Markets ETF | 0.0 | 69 | -4 | 8.8 | +5.5 |
| IEMG | iShares Core MSCI Emerging Markets ETF | 0.0 | 9 | 56 | 9.0 | +5.8 |
| DBAW | Xtrackers MSCI All World ex US Hedged Equity ETF | 0.0 | 41 | 24 | 6.4 | +3.1 |
| DFAX | Dimensional World ex U.S. Core Equity 2 ETF | 0.0 | 30 | 35 | 6.7 | +3.5 |
| BKF | iShares MSCI BIC ETF | 0.0 | 69 | -4 | 14.1 | +10.8 |
| LDEM | iShares ESG MSCI EM Leaders ETF | 0.0 | 17 | 48 | 12.8 | +9.5 |
| EEMX | SPDR MSCI Emerging Markets Fossil Fuel Reserves Free ETF | 0.0 | 30 | 35 | 9.0 | +5.7 |
| EEMA | iShares MSCI Emerging Markets Asia ETF | 0.0 | 49 | 16 | 8.7 | +5.4 |
| DFEV | Dimensional Emerging Markets Value ETF | 0.0 | 43 | 22 | 10.6 | +7.4 |
| VEU | Vanguard FTSE All-World ex-US Index Fund | 0.0 | 4 | 61 | 7.1 | +3.9 |
| VSGX | Vanguard ESG International Stock ETF | 0.0 | 10 | 55 | 7.1 | +3.9 |
| SPGM | SPDR Portfolio MSCI Global Stock Market ETF | 0.0 | 9 | 56 | 5.2 | +2.0 |
| VXUS | Vanguard Total International Stock ETF | 0.0 | 5 | 60 | 7.0 | +3.8 |
| AAXJ | iShares MSCI All Country Asia ex Japan ETF | 0.0 | 70 | -5 | 7.9 | +4.7 |
| VSS | Vanguard FTSE All-World ex-US Small-Cap ETF | 0.0 | 8 | 57 | 6.5 | +3.3 |
| AQLT | iShares MSCI Global Quality Factor ETF | 0.0 | 18 | 47 | 0.0 | -3.2 |
| ACWI | iShares MSCI ACWI ETF | 0.0 | 32 | 33 | 5.1 | +1.8 |
| VT | Vanguard Total World Stock ETF | 0.0 | 6 | 59 | 5.4 | +2.2 |
| GXUS | Goldman Sachs MarketBeta Total International Equity ETF | 0.0 | 18 | 47 | 6.7 | +3.5 |
| JHEM | John Hancock Multifactor Emerging Markets ETF | 0.0 | 49 | 16 | 8.3 | +5.1 |
1Overlap is the percentage of holdings by weight that are identical. For example, if Fund A has a 2% position in Apple, Inc. (AAPL) and Fund B has a 5% position, their overlapping position in AAPL is 2%.
Content on this tab for subscribers only**
RESULTS & ESTIMATES
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | |
|---|---|---|---|---|---|---|---|
| Sales per share | ** | ** | ** | ** | ** | ** | ** |
| Earnings per share | ** | ** | ** | ** | ** | ** | ** |
Dividends per share ![]() |
** | ** | ** | ** | ** | ** | ** |
| Book value per share | ** | ** | ** | ** | ** | ** | ** |
| Sales per share growth | **% | **% | **% | **% | **% | **% | |
| EPS growth | **% | **% | **% | **% | **% | **% |
| Sales per share growth | **% | **% | **% | **% | **% | **% | |
| EPS growth | **% | **% | **% | **% | **% | **% |
OTHER FUNDAMENTAL METRICS
| Long term EPS growth est. | **% | Debt-to-equity | **x | |
| Asset turnover | **% | Assets-to-equity | **x |
| *Six months ago = 100 |
Content on this tab for subscribers only
VALUATION METRICS
| 2024 | 2025E | 2026E | |
|---|---|---|---|
| Price-to-sales | ** | ** | ** |
| Price-to-earnings | ** | ** | ** |
| Price-to-cash flow | ** | ** | ** |
| Price-to-growth | ** | ** | ** |
| Price-to-book value | ** | ** | ** |
| Yield | ** | ** | ** |
Historical valuation trends
| Forward multiple: |
VanEck ChiNext ETF | |||
| Relative to: |
S&P500 | MSCI EAFE | MSCI Emg. Mkts. | Other ETF: |
AVOID |
| Not worthwhile for most investors. A rating of AVOID is assigned to ETFs with ALTAR Scores in the lowest quintile (the bottom 20%) of their category. Often, funds in this category consist of stocks with little if any history or expectation of profitability, and as a result our fundamentally-driven analysis may not be relevant. |
|
ALTAR Score™
|
MODERN PORTFOLIO THEORY
![]() |
||||||||||||||||||||
CONSENSUS RECOMMENDATIONS: FUND CONSTITUENTS
|
||||||||||||||
